
Inhalation Sciences Investor Relations Material
Latest events

Study Result
Inhalation Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Inhalation Sciences
Access all reports
Inhalation Sciences Sweden AB (ISAB) develops and markets laboratory equipment designed for inhalation research. The company’s primary offerings include systems such as PreciseInhale, which allows scientists to measure how inhaled particles behave in the lungs, and DissolvIt, a tool for in vitro simulation of particle dissolution and absorption in the lung epithelium. Their portfolio also includes specialized modules like XposeALI, for 3D cell exposure, and other equipment used in preclinical testing of inhalation drugs and toxicity studies. Inhalation Sciences serves industries involved in respiratory medicine, toxicology, and aerosol science. The company is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ISAB
Country
🇸🇪 Sweden